MicroTargeting® platform: an individual stereotaxic device in functional neurosurgery
2007
Object: Deep brain stimulation of the Nucleus subthalamicus (DBS-STN) results in an improvement of cardinal symptoms of Parkinson disease (PD) and allows a significant reduction of medication. Because of the potential risk of inaccuracies during image acquisition, planning procedure, placement of test electrodes and final electrode insertion a microTargeting® platform, FHC Company, Germany, as an example of automation in stereotaxic neurosurgery was used.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
10
References
4
Citations
NaN
KQI